ClinicalTrials.Veeva

Menu

Effect of Artificial Tears on Biometry

Weill Cornell Medicine (WCM) logo

Weill Cornell Medicine (WCM)

Status and phase

Withdrawn
Phase 4

Conditions

Cataract

Treatments

Drug: Systane Complete

Study type

Interventional

Funder types

Other

Identifiers

NCT04230720
19-11021101

Details and patient eligibility

About

The purpose of this study is to determine if measurements for cataract surgery are improved with use of additional lubrication with artificial tears. The research study is being done to optimize measurements and provide patients with the best visual outcomes after cataract surgery.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female ≥ 18 years of age
  • Documentation of bilateral age-related senile cataracts diagnosis

Exclusion criteria

  • Patients currently using regularly scheduled artificial tears. Patients with infrequent or irregular use of artificial tears may not be excluded from the study.
  • Patients using contact lenses.
  • Patients with any other surface pathology affecting corneal biometric measurements determined with slit-lamp examination or medical history.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Artificial Tears
Experimental group
Description:
One eye of each participant is randomized to receive Systane Complete artificial tears 4 times a day for 14 days
Treatment:
Drug: Systane Complete
No Artificial Tears
No Intervention group
Description:
One eye of each participant is randomized to receive no artificial tears for 14 days

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems